粪便免疫化学试验低于阳性阈值的变化与晚期结直肠肿瘤短期风险:基于人群的癌症筛查项目结果
在基于人群的结直肠癌筛查项目中,分析42,524人连续两次粪便免疫化学试验(FIT)阴性结果(nFIT)浓度与后续筛查发现的晚期肿瘤及间期癌(IC)风险的关系。nFIT值升高者后续阳性及诊断为晚期肿瘤或IC的概率上升;与两次均不可检出者相比,两次高nFIT者OR为21.75(95%CI 12.44–38.04),一次低nFIT加一次高nFIT者OR约为20。
要点
- 连续两次FIT阴性者中,nFIT值越高,后续筛查阳性并诊断晚期肿瘤或IC的概率越高。
- 与两次均不可检出nFIT相比,两次高nFIT者晚期肿瘤或IC的OR为21.75(95%CI 12.44–38.04)。
- 一次低nFIT加一次高nFIT者OR约为20,提示低于阳性阈值的FIT变化具有风险分层价值。
核心结论
- nFIT结果高于检测限的参与者,在后续参与筛查时晚期肿瘤和IC风险增加。
- 该信息可用于设计个性化筛查策略。
研究设计与样本
- 基于人群的结直肠癌筛查项目分析,共纳入42,524人。
- FIT结果分为不可检出nFIT(0–3.8 μg血红蛋白/g粪便)、低nFIT(3.9–9.9)和高nFIT(10.0–19.9)。
- 采用多变量调整逻辑回归估计前两次筛查nFIT结果与晚期肿瘤及IC的比值比(OR)。
主要发现
- 42,524人中,第一次和第二次筛查时超过90%的人nFIT不可检出;低nFIT分别占4.5%和5.8%,高nFIT分别占2.2%和2.9%。
- 随着nFIT值升高,检测阳性并被诊断为晚期肿瘤或IC的概率上升。
- 与两次nFIT均不可检出者相比,两次高nFIT者OR最高,为21.75(95%CI 12.44–38.04);一次低nFIT加一次高nFIT者OR约为20。
关键数值与推荐
- nFIT分类阈值:不可检出0–3.8 μg血红蛋白/g粪便,低nFIT 3.9–9.9,高nFIT 10.0–19.9。
- 两次高nFIT者相比两次不可检出者,晚期肿瘤或IC的OR为21.75(95%CI 12.44–38.04)。
- 一次低nFIT加一次高nFIT者相比两次不可检出者,OR约为20。
临床怎么用
- 原文结论指出nFIT结果高于检测限与后续晚期肿瘤和IC风险增加相关,该信息可用于设计个性化筛查策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Increased values in the fecal immunochemical test (FIT) are correlated with increasingly severe colorectal neoplasia, but little attention has been given to FIT values below the cut-off point (negative FIT, nFIT). We analysed the relationship between the concentrations of two consecutive nFIT and the risk of following screen-detected advanced neoplasia and interval cancer (IC) in a population-based colorectal cancer screening program. METHODS: FIT results were categorised into non-detectable nFIT (0-3.8 μg haemoglobin/g feces), low nFIT (3.9-9.9) and high nFIT (10.0-19.9). Multivariable adjusted logistic regression was used to estimate the odds ratios (OR) of advanced neoplasia and IC with the nFIT results in the first two screens. RESULTS: More than 90% of the 42,524 persons had non-detectable nFIT in the first and second screen; 4.5% and 5.8% had a low nFIT, respectively, and 2.2% and 2.9% had a high nFIT. The probability of testing positive and being diagnosed of advanced neoplasia or IC rose with increasing values of nFIT. Compared with those with two non-detectable nFIT results, the highest OR were found among those who had two high nFIT results (OR 21.75; 95% confidence interval: 12.44, 38.04) and those with one low nFIT and one high nFIT (ORs around 20). CONCLUSIONS: Participants with nFIT results above the detection limit of the test had an increased risk of advanced neoplasia and IC in subsequent participations. This information could be used in the design of personalised screening strategies.
引用
- Buron A, Román M, Augé JM, et al. Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program. Eur J Cancer. 2018. PMID: 30544059. doi:10.1016/j.ejca.2018.11.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。